Document Detail


Successfully treated sulphasalazine-induced fulminant hepatic failure, thrombocytopenia and erythroid hypoplasia with intravenous immunoglobulin.
MedLine Citation:
PMID:  9776124     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We report the simultaneous development of fulminant hepatic failure, thrombocytopenia and erythroid hypoplasia in a child treated with sulphasalazine. A 12-year-old girl with juvenile rheumatoid arthritis developed fulminant hepatic failure, thrombocytopenia and erythroid hypoplasia, which was confirmed by liver histology and bone marrow examination, 2 weeks after initiation of sulphasalazine therapy. The patient recovered after administration of high doses of intravenous immunoglobulin. This is the first reported case of the concurrent development of these complications associated with sulphasalazine hypersensitivity. The use of intravenous immunoglobulin may have helped in the treatment of this rare adverse effect of sulphasalazine.
Authors:
J L Huang; I J Hung; L C Chen; W Y Lee; C Hsueh; K H Hsieh
Related Documents :
11523884 - Oral submucous fibrosis in a 11-year-old bangladeshi girl living in the united kingdom.
15859444 - Hallucinations and delirium in the dental office following triazolam administration.
24464444 - Endocrine disorders in woodhouse-sakati syndrome: a systematic review of the literature.
1551284 - An idiopathic hypereosinophilic syndrome mimicking seronegative rheumatoid arthritis: 2...
16275404 - Locations of congenital cholesteatoma in the middle ear in japanese patients.
9990794 - Gossypiboma revisited: a case report and review of the literature.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Clinical rheumatology     Volume:  17     ISSN:  0770-3198     ISO Abbreviation:  Clin. Rheumatol.     Publication Date:  1998  
Date Detail:
Created Date:  1998-12-15     Completed Date:  1998-12-15     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8211469     Medline TA:  Clin Rheumatol     Country:  BELGIUM    
Other Details:
Languages:  eng     Pagination:  349-52     Citation Subset:  IM    
Affiliation:
Department of Pediatrics, Chang Gung Children's Hospital and Chang Gung University, Taoyuan, Taiwan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antirheumatic Agents / adverse effects*
Arthritis, Juvenile Rheumatoid / drug therapy
Child
Female
Follow-Up Studies
Hepatic Encephalopathy / chemically induced,  complications,  therapy*
Humans
Immunoglobulins, Intravenous / therapeutic use*
Red-Cell Aplasia, Pure / chemically induced,  complications,  therapy*
Sulfasalazine / adverse effects*
Thrombocytopenia / chemically induced,  complications,  therapy*
Chemical
Reg. No./Substance:
0/Antirheumatic Agents; 0/Immunoglobulins, Intravenous; 599-79-1/Sulfasalazine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Factor XIII insufficiency in a patient with severe psoriasis vulgaris, arthritis, and infirmity.
Next Document:  Uncommon features of polyarteritis nodosa: psychosis and angio-oedema.